- Reaction score
- 452
I wish that were true, but if it were, Replicel would be a $5 stock. Instead it has lost half its value in the last 12 months, and had to do two life-preserver rounds of private placement funding to stay afloat. It’s jusy not reasonable to believe it’s going to happen for Replicel next year.
The best protocol that is absolutely going to be released is Follica’s, likely in 2019-2020. I would be shocked and depressed if Follica wasn’t released before 2021. If that’s the case, I give up and will get a transplant (which by then, ARTAS should have a bot that can harvesting AND implant, which will be a game changer for the hair transplant industry).
I agree with you. It's not going to happen for Replicel next year. It will happen for Shiseido though or at the very least, it is likely to. Replicel is a sh*t company that fortunately stumbled on to some good tech which Shiseido will develop and market.
Replicel's stock is sh*t not because the tech doesn't work, it's because investors don't have any faith in replicel's ability to actually bring it to market effectively in the near future. Replicel admits that while Shiseido could potentially launch RCH-01 in the near future (2018) it will still be several more years before it comes to market in the west (2021 or something).
I guarantee you though, once/if Shiseido announces positive results to their phase II and a release date, Replicel's stock will rise, probably to the $ 3 - $5 range. All it took was a roadmap letter from the CEO last january to get it up to $1.30.
Thank God for Shiseido, they have literally saved RCH-01 and Replicel for that matter.
Edit: My reasons for stating Replicel is a sh*t company mostly stem from how they reneged on their agreement with Shiseido in regards to the phase II trial. They basically contracted out all of the risk to Shiseido, which is rational on their part but reflects poor ethics. That being said, it is in our best interests for Replicel to succeed as a company and they could still be very successful investment if you hold a long position for a long enough time (years...). When you consider they also have a treatment to reverse skin damage/aging as well, it could be worth the wait.
Last edited: